Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 238,226,935 papers from all fields of science
Search
Sign In
Create Free Account
Importal
Known as:
Emportal
, Neda Lactiv Importal
, Novartis
A Swiss multinational pharmaceutical company that is engaged in the development, manufacturing, and marketing of healthcare products.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
lactitol
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
Efficacy of satralizumab (SA237) in subgroups of patients in SAkuraSky: a Phase III double-blind, placebo-controlled, add-on study in patients with neuromyelitis optica spectrum disorder (NMOSD) (S43…
T. Yamamura
,
I. Kleiter
,
+10 authors
J. Seze
Neurology
2019
Corpus ID: 201156952
Objective: To evaluate the efficacy of satralizumab (SA237) in subgroups of the SAkuraSky study (NCT02028884). Background…
Expand
2017
2017
Longer Term Follow-up on the First Patients with Severe Hemoglobinopathies Treated with Lentiglobin Gene Therapy
M. Cavazzana
,
S. Hacein-Bey-Abina
,
+27 authors
J. Ribeil
2017
Corpus ID: 182737203
Background: LentiGlobin Drug Product (DP) contains autologous CD34+ cells transduced with the betibeglogene darolentivec (BB305…
Expand
2017
2017
Results from the Hgb-207 (Northstar-2) Trial: A Phase 3 Study to Evaluate Safety and Efficacy of Lentiglobin Gene Therapy for Transfusion-Dependent β-Thalassemia (TDT) in Patients with Non-β0/β0…
M. Walters
,
S. Hongeng
,
+10 authors
A. Thompson
2017
Corpus ID: 199608952
Background Gene therapy with LentiGlobin Drug Product (DP), which contains autologous CD34+ hematopoietic stem cells transduced…
Expand
2009
2009
Comprar Nanotoxicity: From In Vivo and In Vitro Models to Health Risks | Novartis Foundation | 9780470741375 | Wiley
S. Sahu
,
D. Casciano
2009
Corpus ID: 80207779
Tienda online donde Comprar Nanotoxicity: From In Vivo and In Vitro Models to Health Risks al precio 147,42 € de Novartis…
Expand
2004
2004
Telbivudine/Torcitabine Idenix/Novartis.
Hodge Ra
2004
Corpus ID: 56790669
Idenix (formerly Novirio) and Novartis are developing two beta-L-deoxynucleosides, telbivudine and torcitabine, for the potential…
Expand
2003
2003
Bio-Conservation or Bio-Exploitation: An Analysis of the Active Ingredients Discovery Agreement between the Brazilian Institution Bioamazonia and the Swiss Pharmaceutical Company Novartis
R. Scott
2003
Corpus ID: 141088889
I. INTRODUCTION The Amazon Region (Amazon) is the richest source of biodiversity in the world today,1 containing approximately…
Expand
2002
2002
CONTROL OF APHID VECTOR SPREAD OF LILY SYMPTOMLESS VIRUS AND LILY MOTTLE VIRUS BY MINERAL OIL/INSECTICIDE SPRAYS IN LILIUM
C. J. Asjes
,
G. J. Blom-Barnhoorn
2002
Corpus ID: 90508363
The inhibitory effect of mineral oil, synthetic pyrethroid insecticide, organophosphorus insecticide and a pyridine azomethine…
Expand
2002
2002
Endocrine facets of ageing
D. Chadwick
,
J. Goode
2002
Corpus ID: 141861784
Chair's Introduction (J.D. Veldhuis) Endocrine aspects of healthy ageing in men(A.W. van den Beld and S.W.J. Lamberts) Ageing…
Expand
2001
2001
Understanding atopic dermatitis: pathophysiology and etiology. Introduction.
Jon M. Hanifin
,
J. Saurat
Journal of American Academy of Dermatology
2001
Corpus ID: 4859947
This article is part of a supplement sponsored by Novartis Pharma AG and Novartis Pharmaceuticals Corporation. Presented at the…
Expand
1999
1999
Neda Božinović: žensko pitanje u Srbiji u XIX i XX veku
Nataša Mišković
1999
Corpus ID: 181294591